REGN - Regeneron Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
No. of analysts19192828
Avg. Estimate6.135.6926.1130.45
Low estimate4.781.9621.9425.03
High estimate7.388.1533.2437.76
Year ago EPS4.456.0224.6726.11
Revenue estimateCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
No. of analysts16172526
Avg. Estimate1.76B1.7B7.65B8.72B
Low estimate1.55B1.14B6.73B7.42B
High estimate1.92B2.34B9.19B10.99B
Year ago sales1.71B1.93B7.86B7.65B
Sales growth (year/est)2.70%-12.30%-2.70%13.90%
Earnings history30/03/201929/06/201929/09/201930/12/2019
Est. EPS5.475.416.366.92
Actual EPS4.456.026.677.5
Difference-1.020.610.310.58
Surprise %-18.60%11.30%4.90%8.40%
EPS trendCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
Current estimate6.135.6926.1130.45
7 days ago6.245.9826.4430.28
30 days ago6.326.427.1229.88
60 days ago6.477.0728.0629.78
90 days ago6.346.7626.2127.27
EPS revisionsCurrent qtr. (Mar 2020)Next qtr. (Jun 2020)Current year (2020)Next year (2021)
Up last 7 daysN/A111
Up last 30 days63814
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/A11
Growth estimatesREGNIndustrySectorS&P 500
Current qtr.37.80%N/AN/A-0.34
Next qtr.-5.50%N/AN/A-0.12
Current year5.80%N/AN/A-0.18
Next year16.60%N/AN/A0.26
Next 5 years (per annum)6.73%N/AN/A0.04
Past 5 years (per annum)21.60%N/AN/AN/A